Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population

BACKGROUND & AIMS: Antiviral therapy could reduce the risk of hepatocellular carcinoma (HCC) among persons with chronic hepatitis B virus (HBV) infection. We evaluated the relationship between therapy for chronic HBV infection and HCC incidence using data from a longitudinal study of patients at...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Gastroenterol Hepatol
Main Authors: Gordon, Stuart C., Lamerato, Lois E., Rupp, Loralee B., Li, Jia, Holmberg, Scott D., Moorman, Anne C., Spradling, Philip R., Teshale, Eyasu H., Vijayadeva, Vinutha, Boscarino, Joseph A., Henkle, Emily M., Oja–Tebbe, Nancy, Lu, Mei
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5719871/
https://ncbi.nlm.nih.gov/pubmed/24107395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2013.09.062
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados